You are viewing an incomplete version of our website. Please click to reload the website as full version.

Bcl2 Modifying Factor (BMF) (C-Term) Peptide

Details for Product No. ABIN1382118, Supplier: Log in to see
Protein Name
  • BMF
  • AW260063
  • AW411872
Protein Region
C-Term
Origin
Human
1
Application
Blocking Peptide (BP)
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Blocked Antibody anti-BMF antibody (Bcl2 Modifying Factor) (C-Term) (ABIN1030299)
Characteristics 14 amino acids near the carboxy terminus of human Bmf.
Human
Research Area Signaling, Cytoskeleton, Apoptosis/Necrosis, Cancer
Application Notes Bmf peptide is used for blocking the. activity of Bmf.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Funke, Dakoji, Bredt: "Membrane-associated guanylate kinases regulate adhesion and plasticity at cell junctions." in: Annual review of biochemistry, Vol. 74, pp. 219-45, 2005 (PubMed).

Puthalakath, Villunger, OReilly et al.: "Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis." in: Science (New York, N.Y.), Vol. 293, Issue 5536, pp. 1829-32, 2001 (PubMed).

Bilder, Perrimon: "Localization of apical epithelial determinants by the basolateral PDZ protein Scribble." in: Nature, Vol. 403, Issue 6770, pp. 676-80, 2000 (PubMed).